"Neopterin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.
Descriptor ID |
D019798
|
MeSH Number(s) |
D03.633.100.733.631.202.500 D08.211.090.500
|
Concept/Terms |
Neopterin- Neopterin
- 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone
|
Below are MeSH descriptors whose meaning is more general than "Neopterin".
Below are MeSH descriptors whose meaning is more specific than "Neopterin".
This graph shows the total number of publications written about "Neopterin" by people in this website by year, and whether "Neopterin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Neopterin" by people in Profiles.
-
A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med. 2007 Dec; 69(9):850-4.
-
Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis. 2007 Oct; 59(2):131-6.
-
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12. J Immunother. 2003 May-Jun; 26(3):270-6.
-
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. Clin Cancer Res. 2000 Oct; 6(10):3895-903.
-
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy. Melanoma Res. 1998 Apr; 8(2):149-55.
-
Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss. AIDS Res Hum Retroviruses. 1997 Nov 20; 13(17):1533-7.
-
Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia. J Interferon Res. 1994 Dec; 14(6):349-55.
-
Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration. J Clin Oncol. 1992 Aug; 10(8):1310-6.
-
IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients. Haematologica. 1991 Sep-Oct; 76(5):375-82.
-
Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol. 1989 Jan; 25(1):56-60.